Bond Laboratories, Inc. (OTCBB:BNLB) (“Bond Labs”), a national provider of innovative and proprietary nutritional supplements for health conscious consumers, today announced significant continued revenue growth and positive net income for the second fiscal quarter. Revenue for the three months ended June 30, 2012 was $5.2 million as compared to $3.2 million for the comparable period in 2011, an increase of more than 63%. Net income for the three months ended June 30, 2012 was $0.8 million as compared to $0.4 million for the comparable period in 2011, an increase of almost 96%. For the six month period ended June 30, 2012, Bond Labs reported revenue and net income of $10.1 million and $1.5 million, respectively, as compared $6.2 million and $0.5 million for the comparable six month period last year.
“The first half of 2012 saw Bond Labs achieve a number of exciting milestones that both validate our business model and pave the way for our continued growth and international expansion. Bond Labs’ mission is to deliver innovative, high-quality products and solutions that offer truly differentiated outcomes for our customers’ athletic performance, weight loss and general health needs. I am excited about our results and look forward to continuing to execute on our growth strategy,” commented John Wilson, CEO of Bond Labs.
Key milestones achieved in the quarter ended June 30, 2012 include the following:
- Reported revenue of more than $10 million for a six month period for the first time in the history of the Company,
- Successfully launched three exciting new products – Pump Fuel® v2, Pump Fuel® Insanity and Nitro CMX,
- Settled and dismissed the outstanding legal matter among the Company, the Department of Labor and Eric Schick, and
- Opened international markets with our first non-domestic shipments to both Australia and Spain with other markets expected to launch in the near future.
About Bond Labs
Bond Laboratories is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers. The Company produces and markets products through its NDS Nutrition division. NDS’ products number over 60 brands of energy, sports, and dietary supplements. These products are sold directly through specialty health and nutrition retailers, and are included among the top-selling products at GNC® franchises. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit http://www.bond-labs.com.
Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. The company does not undertake any responsibility to update the forward-looking statements contained in this release.